C OSBORNE's research topics

C OSBORNE

Concepts (725)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Breast Neoplasms	249	2015	2658	7.950	Why?
Receptors, Estrogen	114	2015	732	5.120	Why?
Tamoxifen	74	2011	350	4.720	Why?
Antineoplastic Agents, Hormonal	48	2011	256	4.240	Why?
Poaceae	9	2025	15	2.000	Why?
Antineoplastic Combined Chemotherapy Protocols	48	2015	1351	1.940	Why?
Receptors, Progesterone	46	2012	681	1.870	Why?
Estrogen Antagonists	23	2011	92	1.630	Why?
Drug Resistance, Neoplasm	24	2011	819	1.420	Why?
Neoplasms, Hormone-Dependent	19	2011	92	1.390	Why?
Biomarkers, Tumor	30	2013	1624	1.310	Why?
Photosynthesis	5	2025	12	1.280	Why?
Estradiol	22	2010	482	1.210	Why?
Antineoplastic Agents	25	2015	1811	1.020	Why?
Quinazolines	7	2015	181	0.950	Why?
Estrogen Receptor Modulators	10	2005	39	0.840	Why?
DNA, Neoplasm	18	2013	287	0.780	Why?
Plant Leaves	5	2025	56	0.770	Why?
Aromatase Inhibitors	10	2015	78	0.760	Why?
Selective Estrogen Receptor Modulators	7	2010	51	0.750	Why?
Water	3	2025	189	0.750	Why?
Growth Substances	9	2004	102	0.730	Why?
Antibodies, Monoclonal, Humanized	5	2015	578	0.720	Why?
Cyclophosphamide	34	2011	440	0.690	Why?
Female	215	2015	71459	0.680	Why?
ErbB Receptors	16	2011	298	0.650	Why?
Chemotherapy, Adjuvant	25	2010	394	0.630	Why?
Estrogens	19	2006	436	0.620	Why?
Gene Expression Regulation, Neoplastic	22	2009	2031	0.610	Why?
Neoplasm Metastasis	22	2015	710	0.600	Why?
Nitriles	8	2015	165	0.580	Why?
Lymphatic Metastasis	34	2009	433	0.570	Why?
Cell Division	35	2003	720	0.560	Why?
Doxorubicin	22	2011	301	0.560	Why?
Humans	265	2015	132194	0.560	Why?
Tumor Cells, Cultured	28	2003	986	0.550	Why?
Fluorouracil	29	2010	135	0.520	Why?
Receptor Cross-Talk	5	2011	36	0.520	Why?
Gene Transfer, Horizontal	2	2019	45	0.510	Why?
Disease-Free Survival	30	2010	910	0.510	Why?
Carcinoma	4	2015	284	0.510	Why?
Triazoles	8	2015	144	0.490	Why?
Receptors, Growth Factor	3	2005	36	0.490	Why?
Carbon Dioxide	2	2014	272	0.470	Why?
Prognosis	59	2015	4965	0.460	Why?
Droughts	2	2021	12	0.460	Why?
Plant Proteins	2	2013	86	0.460	Why?
Genes, Plant	2	2019	38	0.430	Why?
Mice, Nude	24	2008	713	0.400	Why?
Evolution, Molecular	3	2019	659	0.400	Why?
Mucin-1	1	2013	34	0.390	Why?
Signal Transduction	21	2011	4699	0.390	Why?
Insulin-Like Growth Factor I	10	2006	324	0.380	Why?
Estrogen Receptor alpha	6	2008	433	0.370	Why?
Clinical Trials as Topic	16	2011	1140	0.360	Why?
Drug Resistance	14	2005	248	0.360	Why?
Immunohistochemistry	16	2010	1614	0.360	Why?
Middle Aged	85	2011	28963	0.340	Why?
Pregnancy Complications, Neoplastic	1	2011	63	0.340	Why?
Aged	67	2011	21304	0.340	Why?
Plants	2	2021	49	0.330	Why?
Survival Analysis	23	2007	1522	0.330	Why?
Lymph Nodes	15	2009	364	0.330	Why?
Receptors, Cell Surface	11	1995	433	0.320	Why?
Adenocarcinoma	9	2009	1006	0.320	Why?
Methotrexate	23	2010	344	0.320	Why?
Gene Expression Profiling	8	2015	1851	0.320	Why?
Sirolimus	1	2012	230	0.320	Why?
Prednisone	17	2011	245	0.310	Why?
Repressor Proteins	6	2005	782	0.310	Why?
Lymphoma	4	2011	331	0.310	Why?
Heat-Shock Proteins	5	2011	178	0.300	Why?
Biological Evolution	4	2023	228	0.300	Why?
Climate Change	3	2021	66	0.290	Why?
Trees	2	2019	20	0.290	Why?
Ovariectomy	5	1998	163	0.290	Why?
Adult	71	2011	31771	0.290	Why?
Proportional Hazards Models	13	2009	1412	0.280	Why?
Vincristine	12	2011	194	0.280	Why?
Immunosuppressive Agents	1	2012	666	0.270	Why?
Nuclear Proteins	7	2005	1226	0.270	Why?
Transcription Factors	6	2003	2462	0.260	Why?
Somatomedins	4	1999	33	0.260	Why?
Aged, 80 and over	24	2011	6935	0.260	Why?
Postmenopause	11	2009	149	0.250	Why?
Antibiotics, Antineoplastic	5	2009	125	0.240	Why?
Ploidies	10	2000	35	0.240	Why?
Genes, erbB-1	1	2005	9	0.230	Why?
Trastuzumab	4	2015	148	0.230	Why?
Enzyme Inhibitors	5	2004	567	0.220	Why?
Animals	55	2018	34291	0.220	Why?
Epidermal Growth Factor	6	2004	116	0.220	Why?
Mitogen-Activated Protein Kinases	3	2003	189	0.220	Why?
Antibodies, Monoclonal	10	2011	985	0.210	Why?
Transcription Factor AP-1	2	2002	112	0.210	Why?
Receptors, Retinoic Acid	2	2003	76	0.200	Why?
Mammary Neoplasms, Experimental	5	1999	237	0.200	Why?
Goserelin	3	2005	4	0.200	Why?
Cell Line	22	2003	2591	0.200	Why?
Combined Modality Therapy	17	2005	1261	0.200	Why?
Neoplasms, Second Primary	1	2005	144	0.200	Why?
Neoplasm Proteins	8	2000	679	0.200	Why?
Adaptation, Physiological	1	2025	262	0.200	Why?
Proto-Oncogene Proteins c-bcl-2	4	1998	173	0.190	Why?
Antineoplastic Agents, Phytogenic	4	2005	102	0.190	Why?
Prostatic Neoplasms	5	1992	1427	0.190	Why?
Computer Simulation	1	2006	681	0.190	Why?
Treatment Outcome	28	2011	13022	0.190	Why?
Ecosystem	2	2020	98	0.190	Why?
Drug Administration Schedule	12	2007	739	0.180	Why?
Insulin-Like Growth Factor II	3	1992	38	0.180	Why?
Tumor Suppressor Protein p53	6	1998	738	0.180	Why?
Carcinoma, Ductal, Breast	4	2010	87	0.180	Why?
Mice	36	2015	18399	0.180	Why?
Genetic Markers	1	2003	606	0.180	Why?
Transforming Growth Factor alpha	4	1994	27	0.180	Why?
Xylem	1	2021	3	0.170	Why?
Survival Rate	15	2005	2154	0.170	Why?
Phylogeny	4	2020	717	0.170	Why?
Acclimatization	1	2021	21	0.170	Why?
Trans-Activators	3	2005	692	0.170	Why?
Transforming Growth Factors	5	1988	18	0.170	Why?
Phenotype	7	2021	4550	0.170	Why?
Transfection	9	2002	960	0.170	Why?
HSP70 Heat-Shock Proteins	2	1998	72	0.160	Why?
Plant Stomata	2	2025	7	0.160	Why?
Taxoids	3	2005	71	0.160	Why?
Neoplasms, Experimental	6	1989	205	0.160	Why?
Predictive Value of Tests	14	2010	2325	0.160	Why?
Genes, erbB-2	3	2011	32	0.160	Why?
Polymorphism, Genetic	4	2010	793	0.160	Why?
Cell Proliferation	6	2011	2488	0.160	Why?
Melphalan	4	2003	44	0.150	Why?
Mitoxantrone	7	1999	29	0.150	Why?
Neoplasm Transplantation	9	2006	361	0.150	Why?
Databases, Factual	2	2021	1230	0.150	Why?
Mesoderm	1	2009	108	0.150	Why?
Domestication	1	2018	4	0.150	Why?
Soil	1	2019	77	0.150	Why?
Crops, Agricultural	1	2018	14	0.150	Why?
Molecular Targeted Therapy	2	2011	387	0.150	Why?
Animals, Domestic	1	2018	37	0.140	Why?
Neoplasm, Residual	1	2009	137	0.140	Why?
Peptides	5	1988	725	0.140	Why?
Nuclear Matrix-Associated Proteins	3	2005	18	0.140	Why?
Recombinant Fusion Proteins	4	2000	695	0.140	Why?
Matrix Attachment Region Binding Proteins	3	2005	18	0.140	Why?
S Phase	8	2000	73	0.140	Why?
Forests	1	2017	14	0.140	Why?
Carbon	2	2019	102	0.140	Why?
Menopause	10	2003	87	0.140	Why?
Multivariate Analysis	7	2004	1407	0.140	Why?
Disease Progression	11	2011	2230	0.130	Why?
Dose-Response Relationship, Drug	8	2007	1624	0.130	Why?
Anticarcinogenic Agents	2	2010	46	0.130	Why?
Time Factors	18	2010	6289	0.130	Why?
Tetrahydronaphthalenes	2	2010	30	0.130	Why?
Double-Blind Method	7	2010	1639	0.130	Why?
Transplantation, Heterologous	8	2006	261	0.130	Why?
Transcriptome	3	2015	1141	0.130	Why?
Cathepsin D	2	1994	16	0.130	Why?
Neoplasm Invasiveness	6	2010	646	0.130	Why?
Drug Evaluation	8	1992	102	0.130	Why?
Receptors, Steroid	4	1992	172	0.120	Why?
Flow Cytometry	9	1999	777	0.120	Why?
Proto-Oncogene Proteins	4	1994	602	0.120	Why?
Loss of Heterozygosity	3	2001	124	0.120	Why?
Axilla	10	2005	43	0.120	Why?
Blotting, Western	5	2003	1019	0.120	Why?
Protein-Tyrosine Kinases	3	2011	226	0.120	Why?
Oxidative Stress	1	2000	812	0.120	Why?
Neoplasm Recurrence, Local	10	2010	1282	0.120	Why?
Phosphorylation	9	2008	1571	0.120	Why?
Hormones	5	1989	165	0.120	Why?
Superoxide Dismutase	2	2010	179	0.110	Why?
Hematopoietic Cell Growth Factors	2	1991	9	0.110	Why?
Receptors, Somatomedin	6	1999	21	0.110	Why?
Megestrol	2	1997	2	0.110	Why?
Models, Biological	5	2025	1396	0.110	Why?
Neutropenia	2	2010	206	0.110	Why?
Polymerase Chain Reaction	4	2009	1490	0.110	Why?
Insulin	7	1984	1152	0.110	Why?
Neoplastic Cells, Circulating	1	2015	78	0.100	Why?
Kinetics	10	1990	1093	0.100	Why?
Immunotoxins	1	1994	21	0.100	Why?
South Africa	1	2014	102	0.100	Why?
Nursing Assessment	1	1993	21	0.100	Why?
Granulocyte-Macrophage Colony-Stimulating Factor	1	1994	71	0.100	Why?
Gene Expression	5	2002	1508	0.100	Why?
Premenopause	5	2005	38	0.100	Why?
Orientation	1	1993	39	0.100	Why?
Mastectomy	7	2005	75	0.100	Why?
Gene Amplification	3	2011	227	0.100	Why?
Analysis of Variance	6	1997	956	0.100	Why?
Phosphoproteins	3	2001	437	0.100	Why?
Logistic Models	5	2010	1841	0.100	Why?
Air	1	2013	23	0.100	Why?
Pyrrolidines	2	2010	47	0.100	Why?
Receptor, IGF Type 1	4	2011	93	0.090	Why?
Histone Deacetylases	2	2005	124	0.090	Why?
Vinblastine	2	2011	55	0.090	Why?
Histone Acetyltransferases	2	2003	224	0.090	Why?
Tyrphostins	1	1992	13	0.090	Why?
Data Collection	2	1993	372	0.090	Why?
Nurses	1	1993	79	0.090	Why?
Mice, Inbred BALB C	7	2004	986	0.090	Why?
Cell Line, Tumor	9	2015	3714	0.090	Why?
Phosphotransferases	1	1992	33	0.090	Why?
Sequence Analysis, Protein	1	2012	48	0.090	Why?
Research Personnel	1	1993	141	0.090	Why?
Promoter Regions, Genetic	5	2006	1221	0.090	Why?
Plasmids	2	2002	457	0.090	Why?
Everolimus	1	2012	48	0.090	Why?
Antibodies, Monoclonal, Murine-Derived	1	2011	62	0.090	Why?
Genes, Tumor Suppressor	3	2001	203	0.090	Why?
Phosphotransferases (Alcohol Group Acceptor)	1	1992	81	0.090	Why?
Bleomycin	1	2011	119	0.090	Why?
Dacarbazine	1	2011	94	0.090	Why?
Nuclear Receptor Coactivator 3	2	2003	257	0.090	Why?
Genetic Vectors	2	1994	908	0.090	Why?
Molecular Sequence Data	5	2012	3534	0.090	Why?
Forecasting	3	2005	360	0.090	Why?
Antineoplastic Agents, Alkylating	3	2010	98	0.080	Why?
Activities of Daily Living	1	1993	410	0.080	Why?
Motivation	1	1993	332	0.080	Why?
Fertility Preservation	1	2011	62	0.080	Why?
Osteoporosis, Postmenopausal	1	2010	31	0.080	Why?
Women's Health	1	2012	143	0.080	Why?
Pyridines	1	1992	259	0.080	Why?
Follow-Up Studies	10	2007	5284	0.080	Why?
Paclitaxel	2	2003	134	0.080	Why?
Cell Cycle	7	2006	599	0.080	Why?
Sequence Alignment	1	2012	590	0.080	Why?
Rituximab	1	2011	175	0.080	Why?
Placebos	1	2011	227	0.080	Why?
Quality of Life	4	2002	2117	0.080	Why?
Health Planning Guidelines	1	2010	33	0.080	Why?
Southwestern United States	3	2010	46	0.080	Why?
Amino Acid Sequence	3	2012	2422	0.080	Why?
Metabolic Networks and Pathways	1	2010	193	0.080	Why?
Peroxidase	1	2009	64	0.080	Why?
Transcription, Genetic	3	2008	1399	0.080	Why?
Acronine	1	1989	1	0.070	Why?
Biopsy, Needle	5	2005	216	0.070	Why?
Treatment Failure	4	2010	353	0.070	Why?
Tumor Necrosis Factor-alpha	1	1991	645	0.070	Why?
Guidelines as Topic	1	2010	201	0.070	Why?
Alkaloids	1	1989	36	0.070	Why?
Apoptosis	4	2005	1863	0.070	Why?
Ki-67 Antigen	3	2000	106	0.070	Why?
Nitric Oxide Synthase Type III	1	2009	187	0.070	Why?
Nuclear Receptor Co-Repressor 1	3	2005	51	0.070	Why?
DNA	4	2006	1441	0.070	Why?
Pregnancy Outcome	1	2011	630	0.070	Why?
Disease Models, Animal	6	2015	4694	0.070	Why?
DNA-Binding Proteins	4	2000	1965	0.070	Why?
Fractures, Bone	1	2010	212	0.070	Why?
Drug Screening Assays, Antitumor	3	1994	111	0.070	Why?
Biopsy	7	2009	1254	0.070	Why?
Drug-Related Side Effects and Adverse Reactions	1	2011	268	0.070	Why?
Transcriptional Activation	2	2000	417	0.070	Why?
Chromatography, High Pressure Liquid	4	1994	330	0.070	Why?
Immunologic Factors	1	1989	193	0.070	Why?
Binding, Competitive	3	2000	147	0.070	Why?
Cell Nucleus	5	2000	573	0.070	Why?
Attitude of Health Personnel	1	1993	721	0.070	Why?
Neoadjuvant Therapy	6	2006	406	0.070	Why?
Anthraquinones	2	1985	9	0.070	Why?
United States	12	2010	11867	0.070	Why?
Estrogen Receptor beta	2	2004	77	0.070	Why?
North America	2	2010	260	0.060	Why?
Protein Binding	5	2004	1674	0.060	Why?
Protein Kinase Inhibitors	1	2011	621	0.060	Why?
Receptors, Interleukin	1	2006	37	0.060	Why?
Ligands	4	2004	487	0.060	Why?
Pain Management	1	1989	203	0.060	Why?
Cytosol	3	1997	139	0.060	Why?
Receptors, Somatotropin	1	2006	9	0.060	Why?
Oligonucleotide Array Sequence Analysis	4	2008	1009	0.060	Why?
Benzamides	1	2006	125	0.060	Why?
Glutathione Transferase	2	2010	147	0.060	Why?
Medroxyprogesterone	2	1985	9	0.060	Why?
Anthracenes	6	1991	9	0.060	Why?
Neoplasms	6	2012	2968	0.060	Why?
Human Growth Hormone	1	2006	75	0.060	Why?
Carrier Proteins	1	1990	1024	0.060	Why?
MicroRNAs	1	2012	901	0.060	Why?
Decision Making	2	2003	693	0.060	Why?
Neoplasm Staging	6	2007	1333	0.060	Why?
Plant Transpiration	1	2025	3	0.060	Why?
Tumor Stem Cell Assay	1	1985	34	0.060	Why?
Colony-Forming Units Assay	1	1985	63	0.060	Why?
Mastectomy, Radical	3	2003	9	0.060	Why?
RNA, Messenger	5	2002	2585	0.060	Why?
Prospective Studies	5	2010	6548	0.050	Why?
Drug Approval	1	2005	46	0.050	Why?
p38 Mitogen-Activated Protein Kinases	1	2005	125	0.050	Why?
Insulin-Like Growth Factor Binding Proteins	2	1997	33	0.050	Why?
Proteinuria	1	2005	107	0.050	Why?
Dog Diseases	1	2005	58	0.050	Why?
JNK Mitogen-Activated Protein Kinases	2	2002	85	0.050	Why?
RNA, Neoplasm	4	1990	126	0.050	Why?
In Situ Hybridization	2	1995	452	0.050	Why?
Injections, Intramuscular	1	2004	187	0.050	Why?
Cell Size	1	2023	79	0.050	Why?
Androstenedione	1	2003	15	0.050	Why?
Metallothionein	2	1994	16	0.050	Why?
Nuclear Receptor Coactivator 1	1	2003	162	0.050	Why?
Algorithms	4	2010	1690	0.050	Why?
Homeodomain Proteins	1	2006	571	0.050	Why?
Oncogene Proteins, Viral	2	1994	61	0.050	Why?
Acetyltransferases	1	2003	73	0.050	Why?
Creatinine	1	2005	403	0.050	Why?
Clinical Trials, Phase III as Topic	3	2009	76	0.050	Why?
Genetic Testing	1	2009	1107	0.050	Why?
Chromosomes, Human, Pair 14	2	2001	96	0.050	Why?
Proteins	2	2001	1014	0.050	Why?
Bone Density	2	2010	362	0.050	Why?
Infusions, Intravenous	3	2007	550	0.050	Why?
Genes, Dominant	1	2003	253	0.050	Why?
Breast	4	2003	217	0.050	Why?
Oncogene Proteins	1	2003	137	0.050	Why?
Lymphoma, Large B-Cell, Diffuse	4	1983	169	0.050	Why?
Structure-Activity Relationship	2	2000	555	0.050	Why?
Cisplatin	4	2009	289	0.050	Why?
Statistics as Topic	3	1999	244	0.050	Why?
Immunoenzyme Techniques	2	2004	237	0.050	Why?
Research	3	1995	268	0.040	Why?
Administration, Oral	1	2004	711	0.040	Why?
Plant Physiological Phenomena	1	2021	7	0.040	Why?
Retrospective Studies	10	2009	17772	0.040	Why?
Mastectomy, Segmental	2	2004	39	0.040	Why?
Hyperbaric Oxygenation	2	1973	20	0.040	Why?
Salvage Therapy	1	2003	177	0.040	Why?
Stereoisomerism	2	1992	115	0.040	Why?
Odds Ratio	3	2010	1237	0.040	Why?
Randomized Controlled Trials as Topic	4	2009	1252	0.040	Why?
BRCA1 Protein	2	1999	83	0.040	Why?
Radioimmunoassay	2	1991	85	0.040	Why?
Phorbols	1	1981	5	0.040	Why?
Nucleoside-Diphosphate Kinase	1	2001	4	0.040	Why?
Climate	1	2021	26	0.040	Why?
Biophysical Phenomena	1	2021	40	0.040	Why?
Australia	1	2021	176	0.040	Why?
Phorbol Esters	1	1981	21	0.040	Why?
Monomeric GTP-Binding Proteins	1	2001	28	0.040	Why?
Chloramphenicol O-Acetyltransferase	1	2000	60	0.040	Why?
Azacitidine	1	2001	52	0.040	Why?
Enhancer Elements, Genetic	1	2002	275	0.040	Why?
Chromosomes, Human, Pair 19	1	2001	60	0.040	Why?
Proto-Oncogene Proteins c-jun	1	2000	35	0.040	Why?
Cold Temperature	1	2021	80	0.040	Why?
Pentose Phosphate Pathway	1	2000	44	0.040	Why?
Muscle Proteins	1	2003	404	0.040	Why?
Proto-Oncogene Proteins c-akt	2	2008	482	0.040	Why?
Plant Dispersal	1	2020	1	0.040	Why?
Lipid Peroxidation	1	2000	91	0.040	Why?
Glucocorticoids	3	1979	352	0.040	Why?
Risk Factors	10	2010	11041	0.040	Why?
Urokinase-Type Plasminogen Activator	2	1997	32	0.040	Why?
Carbon Sequestration	1	2019	6	0.040	Why?
Aneuploidy	1	2000	141	0.040	Why?
Risk Assessment	4	2010	3721	0.040	Why?
Reverse Transcriptase Polymerase Chain Reaction	3	2009	1236	0.040	Why?
Plasminogen Activator Inhibitor 1	2	1997	50	0.040	Why?
Claudin-1	1	2009	19	0.040	Why?
Insulin Antagonists	1	1979	4	0.040	Why?
Protein Kinases	2	2008	322	0.040	Why?
CD24 Antigen	1	2009	32	0.040	Why?
Gene Expression Regulation, Plant	1	2019	63	0.040	Why?
Molecular Weight	2	1990	283	0.040	Why?
Genome	2	2019	474	0.040	Why?
Leukocyte Count	2	2009	249	0.040	Why?
Hyaluronan Receptors	1	2009	64	0.040	Why?
Gene Dosage	2	2008	439	0.040	Why?
Pregnancy	2	2011	7604	0.040	Why?
Patient Selection	3	2009	727	0.040	Why?
Breast Neoplasms, Male	1	1998	18	0.040	Why?
Cyclins	1	1999	94	0.040	Why?
Depression, Chemical	2	2000	34	0.040	Why?
Down-Regulation	3	2005	659	0.040	Why?
Epithelium	1	2009	344	0.040	Why?
Antimetabolites, Antineoplastic	3	2009	189	0.030	Why?
Injections, Intraperitoneal	2	1989	66	0.030	Why?
Hormone Antagonists	1	1998	45	0.030	Why?
Medical Oncology	2	2010	239	0.030	Why?
Aminoglutethimide	1	1997	3	0.030	Why?
Immunoblotting	2	2004	291	0.030	Why?
DNA Replication	2	1989	358	0.030	Why?
Mammography	2	2010	131	0.030	Why?
Centrifugation	1	1997	18	0.030	Why?
Cell Survival	3	1989	849	0.030	Why?
Endometrial Neoplasms	1	1998	110	0.030	Why?
Cytodiagnosis	1	1997	20	0.030	Why?
Cell Movement	1	2001	882	0.030	Why?
Recombinant Proteins	2	1991	1320	0.030	Why?
Cell Membrane	1	2009	457	0.030	Why?
Lung Neoplasms	4	2015	1552	0.030	Why?
Drug Synergism	2	2008	240	0.030	Why?
Telomerase	1	1997	158	0.030	Why?
DNA Primers	4	1999	609	0.030	Why?
Nucleic Acids	2	2012	26	0.030	Why?
Age Factors	3	2007	2869	0.030	Why?
Kidney Failure, Chronic	1	2005	944	0.030	Why?
Thymidine	3	1982	49	0.030	Why?
Receptor, Insulin	5	1999	62	0.030	Why?
Hydrocortisone	1	1997	224	0.030	Why?
Phosphatidylinositol 3-Kinases	1	2008	345	0.030	Why?
Chromosomal Proteins, Non-Histone	1	1997	212	0.030	Why?
Testosterone	1	1982	604	0.030	Why?
Cytoplasm	2	1995	255	0.030	Why?
Polyethylene Glycols	1	1997	241	0.030	Why?
DNA Damage	1	1999	527	0.030	Why?
TOR Serine-Threonine Kinases	1	2008	427	0.030	Why?
Societies, Medical	2	2010	798	0.030	Why?
Male	15	2005	65494	0.030	Why?
Quality-Adjusted Life Years	1	1996	127	0.030	Why?
Interphase	2	1987	35	0.030	Why?
Leukopenia	3	1985	45	0.030	Why?
Hyperplasia	3	2005	189	0.030	Why?
Mutation	4	2003	6207	0.030	Why?
Chromosome Deletion	1	1998	653	0.030	Why?
Remission Induction	2	1998	309	0.030	Why?
Culture Media, Conditioned	1	1994	81	0.030	Why?
Cell Transformation, Neoplastic	2	1998	610	0.030	Why?
Chi-Square Distribution	1	1996	570	0.030	Why?
Clone Cells	3	1985	158	0.030	Why?
Hematopoietic Stem Cell Transplantation	1	2003	1270	0.030	Why?
Palliative Care	1	1998	447	0.030	Why?
Heterografts	1	2015	195	0.030	Why?
DNA Methylation	1	2001	1102	0.030	Why?
Stimulation, Chemical	1	1994	43	0.030	Why?
Isomerism	1	1994	25	0.030	Why?
Follicle Stimulating Hormone	1	1994	188	0.030	Why?
Bone Neoplasms	3	2000	453	0.030	Why?
Hematologic Tests	1	1994	36	0.030	Why?
Cloning, Molecular	2	1993	787	0.030	Why?
Rats	6	2000	3459	0.030	Why?
Castration	3	1985	31	0.030	Why?
Quality Control	1	1993	118	0.030	Why?
Protein Biosynthesis	1	1996	579	0.020	Why?
Vitamin E Deficiency	1	1973	2	0.020	Why?
Peroxides	1	1973	7	0.020	Why?
Dexamethasone	3	1980	260	0.020	Why?
Base Sequence	4	2000	2785	0.020	Why?
Methemoglobinemia	1	1973	9	0.020	Why?
Recurrence	3	2009	1484	0.020	Why?
Chromosome Aberrations	1	1995	578	0.020	Why?
Hemolysis	1	1973	87	0.020	Why?
Xenograft Model Antitumor Assays	2	2008	999	0.020	Why?
Up-Regulation	2	2005	831	0.020	Why?
Erythrocytes	1	1973	191	0.020	Why?
RNA Stability	1	2012	75	0.020	Why?
Carcinoma in Situ	1	1992	72	0.020	Why?
Carcinoma, Intraductal, Noninfiltrating	1	1992	69	0.020	Why?
Membrane Proteins	1	2009	1617	0.020	Why?
Antisense Elements (Genetics)	1	1991	4	0.020	Why?
Gene Expression Regulation	3	1998	2358	0.020	Why?
Electrophoresis, Agar Gel	1	1991	40	0.020	Why?
Templates, Genetic	1	1991	54	0.020	Why?
Oxidoreductases, N-Demethylating	1	2010	9	0.020	Why?
Burnout, Professional	1	1993	131	0.020	Why?
Cytochrome P-450 CYP2B6	1	2010	15	0.020	Why?
Inactivation, Metabolic	1	2010	26	0.020	Why?
Glutathione S-Transferase pi	1	2010	25	0.020	Why?
Aryl Hydrocarbon Hydroxylases	1	2010	41	0.020	Why?
Diethylstilbestrol	1	1990	42	0.020	Why?
Angiogenesis Inhibitors	1	2011	113	0.020	Why?
Sex Hormone-Binding Globulin	1	2010	50	0.020	Why?
Cytochrome P-450 CYP3A	1	2010	51	0.020	Why?
Orchiectomy	1	1990	52	0.020	Why?
False Negative Reactions	1	2010	88	0.020	Why?
Insulin Receptor Substrate Proteins	2	2001	72	0.020	Why?
Bone Density Conservation Agents	1	2010	58	0.020	Why?
Alanine	1	1991	162	0.020	Why?
Cohort Studies	3	2006	5127	0.020	Why?
False Positive Reactions	1	2010	143	0.020	Why?
Uridine	2	1980	31	0.020	Why?
Cancer Vaccines	1	2011	191	0.020	Why?
Research Design	2	2005	718	0.020	Why?
Lipid Metabolism	1	1973	372	0.020	Why?
Karyotyping	2	1987	313	0.020	Why?
Cells, Cultured	7	1987	2947	0.020	Why?
Patient Care Team	1	1993	558	0.020	Why?
Primary Prevention	1	2010	176	0.020	Why?
Microfilament Proteins	2	2003	272	0.020	Why?
Sensitivity and Specificity	2	2010	2144	0.020	Why?
Buserelin	1	1989	1	0.020	Why?
Oncogenes	1	1989	164	0.020	Why?
Cell Adhesion	1	1989	310	0.020	Why?
Solubility	1	1989	117	0.020	Why?
Transforming Growth Factor beta	1	1992	463	0.020	Why?
Bone Marrow Transplantation	1	1991	590	0.020	Why?
Pilot Projects	3	1999	1476	0.020	Why?
Affinity Labels	1	1988	10	0.020	Why?
Biological Availability	1	1989	140	0.020	Why?
Linear Models	1	1990	696	0.020	Why?
Adolescent	3	2005	21021	0.020	Why?
Gene Frequency	1	2010	751	0.020	Why?
CHO Cells	2	2000	149	0.020	Why?
3T3 Cells	2	2000	121	0.020	Why?
Cricetinae	2	2000	366	0.020	Why?
Culture Techniques	2	1978	75	0.020	Why?
Nausea	2	1985	83	0.020	Why?
Fatty Acids	3	1983	379	0.020	Why?
Agar	1	1987	17	0.020	Why?
Biological Products	1	1989	144	0.020	Why?
Microscopy, Electron	1	1987	316	0.020	Why?
Choline Dehydrogenase	1	2006	2	0.020	Why?
Tissue Distribution	2	1997	367	0.020	Why?
Receptors, Interleukin-17	1	2006	7	0.020	Why?
Adrenalectomy	3	1978	40	0.020	Why?
Kaplan-Meier Estimate	1	2009	1082	0.020	Why?
Injections, Subcutaneous	1	1987	134	0.020	Why?
Culture Media	2	1984	175	0.020	Why?
Mitosis	1	1987	190	0.020	Why?
Delayed-Action Preparations	1	1987	121	0.020	Why?
Probability	1	2007	310	0.020	Why?
Response Elements	1	2006	107	0.020	Why?
Evidence-Based Medicine	1	2010	645	0.020	Why?
Ethics, Medical	1	1989	400	0.010	Why?
Statistics, Nonparametric	1	2007	431	0.010	Why?
Immunologic Techniques	1	1985	8	0.010	Why?
Liver Neoplasms	3	2003	1408	0.010	Why?
Endpoint Determination	1	2005	57	0.010	Why?
Health Status Disparities	1	2009	279	0.010	Why?
Chemoprevention	1	2005	51	0.010	Why?
Random Allocation	4	1989	423	0.010	Why?
Phenylalanine	1	1986	125	0.010	Why?
Mammary Glands, Human	1	2006	81	0.010	Why?
Chromatin Immunoprecipitation	1	2005	233	0.010	Why?
Raloxifene Hydrochloride	1	1985	16	0.010	Why?
Risk	2	1998	739	0.010	Why?
Confidence Intervals	1	2005	272	0.010	Why?
Medroxyprogesterone Acetate	1	1985	21	0.010	Why?
Research Support as Topic	1	2005	61	0.010	Why?
Drug Evaluation, Preclinical	1	1984	152	0.010	Why?
Guinea Pigs	1	1984	155	0.010	Why?
Nafoxidine	1	1984	4	0.010	Why?
Phlebitis	1	1984	1	0.010	Why?
Chickens	1	1984	271	0.010	Why?
Growth Hormone	1	1984	127	0.010	Why?
Radiotherapy	1	2004	120	0.010	Why?
Binding Sites	1	2006	1149	0.010	Why?
Patient Care Planning	1	2005	123	0.010	Why?
Rabbits	1	1984	579	0.010	Why?
Dogs	1	2005	623	0.010	Why?
Analgesics, Opioid	1	1989	471	0.010	Why?
Leydig Cell Tumor	1	1983	7	0.010	Why?
Species Specificity	1	1984	496	0.010	Why?
Hypercalcemia	1	1983	42	0.010	Why?
Protein Isoforms	1	2004	421	0.010	Why?
Megestrol Acetate	1	2003	2	0.010	Why?
Bone Resorption	1	1983	49	0.010	Why?
Thiotepa	1	2003	18	0.010	Why?
Editorial Policies	1	2004	49	0.010	Why?
Toremifene	1	2003	1	0.010	Why?
RNA, Small Interfering	1	2005	665	0.010	Why?
Genotype	1	2009	2656	0.010	Why?
Reproducibility of Results	1	2010	2995	0.010	Why?
Case-Control Studies	1	2010	3461	0.010	Why?
Mastectomy, Modified Radical	1	2003	7	0.010	Why?
Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)	1	2002	1	0.010	Why?
Culture Media, Serum-Free	1	2002	23	0.010	Why?
Antibody Specificity	1	2003	162	0.010	Why?
Genes, Neoplasm	1	2003	80	0.010	Why?
Piperidines	1	1985	232	0.010	Why?
Incidence	1	2010	3358	0.010	Why?
Transplantation, Autologous	1	2003	268	0.010	Why?
Progesterone	1	1985	446	0.010	Why?
In Situ Hybridization, Fluorescence	1	2004	755	0.010	Why?
Thyroid Hormones	1	2003	55	0.010	Why?
Cause of Death	1	2005	511	0.010	Why?
Neoplastic Stem Cells	1	1985	331	0.010	Why?
Antigens, Neoplasm	1	2005	402	0.010	Why?
Cell Differentiation	1	1989	1950	0.010	Why?
Thrombocytopenia	1	1983	223	0.010	Why?
Acetates	2	1979	81	0.010	Why?
Spinal Cord Compression	1	1982	31	0.010	Why?
Hemagglutinins	1	2001	24	0.010	Why?
Severity of Illness Index	1	2010	3098	0.010	Why?
Anaphylaxis	1	1983	91	0.010	Why?
Chromosomes, Artificial, Yeast	1	2001	42	0.010	Why?
Physical Chromosome Mapping	1	2001	55	0.010	Why?
NM23 Nucleoside Diphosphate Kinases	1	2001	4	0.010	Why?
Expressed Sequence Tags	1	2001	80	0.010	Why?
Cyclin D1	1	2001	109	0.010	Why?
Regression Analysis	2	1998	772	0.010	Why?
Chromosomes, Artificial, Bacterial	1	2001	90	0.010	Why?
Receptors, Glucocorticoid	2	1979	105	0.010	Why?
Swine	1	1984	1188	0.010	Why?
Precancerous Conditions	1	2003	283	0.010	Why?
Antigens, Nuclear	1	2001	52	0.010	Why?
Menstruation	1	1980	26	0.010	Why?
Drug Therapy, Combination	2	1981	1173	0.010	Why?
Rodentia	1	1980	50	0.010	Why?
Luminescent Proteins	1	2000	155	0.010	Why?
Microsatellite Repeats	1	2001	232	0.010	Why?
Cell Count	1	1980	217	0.010	Why?
Macromolecular Substances	1	2000	131	0.010	Why?
COS Cells	1	2000	249	0.010	Why?
Mitotic Index	1	1999	17	0.010	Why?
CpG Islands	1	2001	341	0.010	Why?
Lymphoma, Non-Hodgkin	2	1983	164	0.010	Why?
Blood-Brain Barrier	1	2000	151	0.010	Why?
Thymidine Kinase	1	1979	89	0.010	Why?
Epithelial Cells	1	2003	902	0.010	Why?
Precipitin Tests	1	1999	108	0.010	Why?
Green Fluorescent Proteins	1	2000	382	0.010	Why?
Leucine	1	1980	261	0.010	Why?
Molecular Probe Techniques	1	1999	23	0.010	Why?
Cyclin-Dependent Kinase Inhibitor p21	1	1999	82	0.010	Why?
Lipids	1	1983	566	0.010	Why?
Reagent Kits, Diagnostic	1	1999	52	0.010	Why?
Mutagens	1	1999	48	0.010	Why?
Adenocarcinoma, Mucinous	1	1999	39	0.010	Why?
Mortality	1	1980	261	0.010	Why?
DNA Mutational Analysis	1	2001	806	0.010	Why?
Genetic Predisposition to Disease	1	2010	3439	0.010	Why?
Calcium-Calmodulin-Dependent Protein Kinases	1	1999	107	0.010	Why?
Estradiol Congeners	1	1978	3	0.010	Why?
Testosterone Congeners	1	1978	15	0.010	Why?
Fluoxymesterone	1	1998	1	0.010	Why?
Nucleic Acid Hybridization	1	1999	299	0.010	Why?
Receptors, Androgen	2	1979	419	0.010	Why?
DNA, Complementary	1	1999	436	0.010	Why?
Mice, Transgenic	1	2003	2367	0.010	Why?
Protein Structure, Tertiary	1	2000	719	0.010	Why?
Oxygen	2	1973	552	0.010	Why?
Nuclear Receptor Co-Repressor 2	1	1998	32	0.010	Why?
Preoperative Care	1	2000	358	0.010	Why?
Neuromuscular Diseases	1	1998	48	0.010	Why?
Breast Diseases	1	1998	38	0.010	Why?
Radiotherapy, Adjuvant	1	1998	157	0.010	Why?
Neoplasms, Multiple Primary	1	1998	62	0.010	Why?
Actuarial Analysis	2	1992	27	0.010	Why?
Hematologic Diseases	1	1998	82	0.010	Why?
Drug Hypersensitivity	1	1998	97	0.010	Why?
Genes, Reporter	1	1998	350	0.010	Why?
Mitomycin	1	1997	48	0.010	Why?
Temperature	1	1978	290	0.010	Why?
Osteosarcoma	1	2000	268	0.010	Why?
Hydrogen-Ion Concentration	1	1978	414	0.010	Why?
Dactinomycin	1	1976	48	0.010	Why?
Repetitive Sequences, Nucleic Acid	1	1997	351	0.010	Why?
Glucose	2	1983	850	0.010	Why?
Aging	1	1984	1274	0.010	Why?
Pain Measurement	1	1998	356	0.010	Why?
Ascites	1	1997	99	0.010	Why?
Intracellular Signaling Peptides and Proteins	1	1999	590	0.010	Why?
Registries	1	2003	1602	0.010	Why?
Income	1	1996	135	0.010	Why?
Cell Fractionation	1	1995	23	0.010	Why?
Metaphase	1	1995	31	0.010	Why?
Pleural Effusion, Malignant	1	1995	13	0.010	Why?
Heterozygote	1	1998	728	0.010	Why?
Tomography, Emission-Computed	1	1995	36	0.010	Why?
Educational Status	1	1996	281	0.010	Why?
Testicular Neoplasms	1	1976	123	0.010	Why?
Buffers	1	1995	27	0.010	Why?
Multicenter Studies as Topic	1	1996	301	0.010	Why?
Tomography, Emission-Computed, Single-Photon	1	1995	101	0.010	Why?
Receptors, Urokinase Plasminogen Activator	1	1995	25	0.010	Why?
National Institutes of Health (U.S.)	1	1995	135	0.010	Why?
Suppositories	1	1994	3	0.010	Why?
Gastrointestinal Diseases	1	1998	340	0.010	Why?
GRB7 Adaptor Protein	1	1994	2	0.010	Why?
Residence Characteristics	1	1996	295	0.010	Why?
Heart Diseases	1	1998	505	0.010	Why?
Hemoglobinuria	1	1973	2	0.010	Why?
Enzyme-Linked Immunosorbent Assay	1	1995	792	0.010	Why?
Oligonucleotides, Antisense	1	1993	73	0.010	Why?
Sequence Homology, Amino Acid	1	1994	622	0.010	Why?
Catalase	1	1973	64	0.010	Why?
Nitrites	1	1973	48	0.010	Why?
Image Processing, Computer-Assisted	1	1995	612	0.010	Why?
Diet	1	1979	1119	0.010	Why?
Lymphoma, Follicular	2	1983	32	0.010	Why?
Ultraviolet Rays	1	1973	192	0.010	Why?
Caenorhabditis elegans	1	1994	251	0.010	Why?
Sodium	1	1973	279	0.010	Why?
Chromosome Mapping	1	1994	1066	0.010	Why?
Ovarian Neoplasms	1	1995	456	0.010	Why?
Atmospheric Pressure	1	1970	5	0.010	Why?
Carcinoma, Hepatocellular	1	2000	1011	0.010	Why?
Adrenal Glands	1	1970	46	0.010	Why?
Mass Spectrometry	1	1992	362	0.010	Why?
Aerospace Medicine	1	1970	39	0.010	Why?
Splenectomy	1	1970	63	0.010	Why?
Spleen	1	1970	257	0.000	Why?
Postoperative Care	1	1992	303	0.000	Why?
Blotting, Northern	1	1989	236	0.000	Why?
Leukocytes	1	1970	212	0.000	Why?
Genes, ras	1	1989	99	0.000	Why?
Ascitic Fluid	1	1988	29	0.000	Why?
Stress, Physiological	1	1970	265	0.000	Why?
Adrenal Cortex Hormones	1	1970	338	0.000	Why?
Proto-Oncogene Proteins c-myc	1	1989	195	0.000	Why?
Surveys and Questionnaires	1	1998	4078	0.000	Why?
Pleural Effusion	1	1988	106	0.000	Why?
Alopecia	1	1985	42	0.000	Why?
Vomiting	1	1985	105	0.000	Why?
Autopsy	1	1983	119	0.000	Why?
Infusions, Parenteral	1	1983	78	0.000	Why?
Deoxyglucose	1	1983	42	0.000	Why?
Endocrine Glands	1	1982	8	0.000	Why?
Phospholipids	1	1983	103	0.000	Why?
Methods	1	1982	110	0.000	Why?
Autoradiography	1	1982	65	0.000	Why?
B-Lymphocytes	1	1983	511	0.000	Why?
Cell Separation	1	1981	221	0.000	Why?
Eggs	1	1979	22	0.000	Why?
Steroids	1	1980	172	0.000	Why?
Milk	1	1979	109	0.000	Why?
Calcium	1	1983	1039	0.000	Why?
Dietary Fats	1	1979	276	0.000	Why?
Acute Disease	1	1980	1154	0.000	Why?
Prolactin	1	1977	112	0.000	Why?
Energy Intake	1	1979	502	0.000	Why?
Androgen Antagonists	1	1977	114	0.000	Why?
Lactation	1	1977	197	0.000	Why?
Androgens	1	1977	272	0.000	Why?
T-Lymphocytes	1	1983	1706	0.000	Why?
Heart Failure	1	1985	2318	0.000	Why?
Child	1	1983	26383	0.000	Why?

OSBORNE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (725)

Explore

Co-Authors (15)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors